Building transparency into rare disease gene therapy trials: what patients and caregivers need to know

  • Understanding why transparency is critical to patient trust and retention in gene therapy trials
  • Recognizing operational challenges unique to gene therapy that impact patients and caregivers
  • Identifying strategies to embed patient and caregiver voices into protocol and schedule design
  • Sharing practical take away communication practices that can strengthen partnerships between trial teams, advocates, and families